Successful Treatment of Refractory Duodenal Crohn’s Disease with Infliximab

By Odashima Masaru   Otaka Michiro   Jin Mario   Horikawa Youhei   Matsuhashi Tamostu   Ohba Reina   Koizumi Shigeto   Kinoshita Nobukatsu   Takahashi Taiji   Watanabe Sumio  

Digestive Diseases and Sciences, Vol. 52, Iss. 1, 2007-01 ,pp. : 31-32

Springer Publishing Company

Access to resources Recommend Favorite

First appearance of Crohn's disease following infliximab treatment for spondylarthropathy

By Tsochatzis Emmanuel   Vassilopoulos Dimitrios   Manesis Emanuel K.   Papatheodoridis George   Bousiotou Ageliki   Hadziyannis Emilia   Archimandritis Athanasios J.  

Scandinavian Journal of Gastroenterology, Vol. 42, Iss. 6, 2007-01 ,pp. : 784-785

Informa Healthcare

Access to resources Recommend Favorite

Toxicity of infliximab in the course of treatment of Crohn’s disease

By Bratcher Jason M   Korelitz Burton I  

Expert Opinion on Drug Safety, Vol. 5, Iss. 1, 2006-01 ,pp. : 9-16

Informa Healthcare

Access to resources Recommend Favorite

Treatment of hidradenitis suppurativa with infliximab in a patient with Crohn's disease

By Rosi Y. L.   Lowe L.   Kang S.  

Journal of Dermatological Treatment, Vol. 16, Iss. 1, 2005-02 ,pp. : 58-62

Informa Healthcare

Access to resources Recommend Favorite

Treatment of Pyoderma Gangrenosum with Infliximab in Crohn's Disease

By Sapienza Mark S.   Cohen Sidney   Dimarino Anthony J.  

Digestive Diseases and Sciences, Vol. 49, Iss. 9, 2004-09 ,pp. : 1454-1457

Springer Publishing Company

Access to resources Recommend Favorite